Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

NCT06785974 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Melanoma
Immune-related Adverse Event

Interventions

DRUG: Atorvastatin
DRUG: Placebo

Sponsor

Erasmus Medical Center

Collaborators

[object Object]